Lemon Berry Candy OG Hybrid (~60% sativa / 40% indica)

Lemon Berry Candy OG is a hybrid cannabis strain leaning slightly toward the sativa side at roughly 60% sativa and 40% indica. It was produced by crossing Las Vegas Lemon Skunk with LGBT, a pairing that brought together complementary genetic profiles to produce a strain with a well-defined sensory character and reliable growing traits. The aroma is led by sharp lemon zest backed by sweet berries and subtle hints of diesel fuel — a combination that is immediately recognizable and stays consistent from flower to finished product. That aromatic profile reflects the terpene makeup directly. Limonene drives the citrus brightness, myrcene contributes an underlying earthiness and softness, and caryophyllene adds a faint spicy depth that keeps the overall nose from reading as purely sweet. On the palate, users commonly report flavors of lemon, candy, berry, and citrus with an earthy finish — closely mirroring what the nose suggests going in. Effects commonly reported by users include feeling uplifted, creative, relaxed, and focused. These experiences are consistent with the strain's sativa-leaning hybrid structure. THC content typically falls in the 20% to 25% range, making this a moderately to fairly potent cultivar. CBD content sits low, generally coming in below 1%, so the cannabinoid profile is THC-dominant throughout. From a cultivation standpoint, Lemon Berry Candy OG is rated at moderate difficulty, meaning it is manageable for growers with some practical experience but may present challenges for complete beginners. It rewards attentive technique with a high yield potential, which makes it an appealing option for cultivators who have the skills to meet its needs. Flowering time runs 8 to 10 weeks, a fairly standard window for a hybrid of this type. Overall, Lemon Berry Candy OG occupies a practical middle ground — expressive enough in aroma and flavor to stand out on the shelf, productive enough in the garden to justify the attention it asks for, and balanced enough in its commonly reported effects to suit a broad range of use occasions. No child strains are documented in the available data at this time.